MOLECULAR DESIGN OF POTENT INHIBITOR SPECIFIC FOR CATHEPSIN-B BASED ON THE TERTIARY STRUCTURE PREDICTION

被引:35
|
作者
SUMIYA, S
YONEDA, T
KITAMURA, K
MURATA, M
YOKOO, C
TAMAI, M
YAMAMOTO, A
INOUE, M
ISHIDA, T
机构
[1] TAISHO PHARMACEUT CO LTD, RES CTR, 1-403 YOSHINO CHO, OMIYA, SAITAMA 330, JAPAN
[2] OSAKA UNIV PHARMACEUT SCI, DEPT PHYS CHEM, MATSUBARA, OSAKA 580, JAPAN
关键词
CA-074; MOLECULAR DESIGN; CATHEPSIN-B; TERTIARY STRUCTURE PREDICTION; PAPAIN-E-64-C COMPLEX; RESTRAINED MOLECULAR DYNAMICS SIMULATION;
D O I
10.1248/cpb.40.299
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To design a potent inhibitor specific for cathepsin B (rat liver), the tertiary structure was predicted based on the crystal structure of the papain complexed with (+)-(2S,3S)-3-{1-[N-(3-methylbutyl)amino]leucylcarbonyl}oxirane-2-carbolylic acid (E-64-c), a thiol protease inhibitor. Taking advantage of the structural characteristics of the predicted active site, seventeen inhibitors were chemically synthesized by molecular modeling, and one of them, N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-proline (CA-074) was shown to be the first potent inhibitor specific for cathepsin B. The relationship between the structure and inhibitory activity is discussed based on the model structure of the cathepsin B-inhibitor complex.
引用
收藏
页码:299 / 303
页数:5
相关论文
共 50 条
  • [41] ANTIPEPTIDE ANTIBODIES TO CATHEPSIN-B, CATHEPSIN-L AND CATHEPSIN-D AND TYPE-IV COLLAGENASE - SPECIFIC RECOGNITION AND INHIBITION OF THE ENZYMES
    COETZER, THT
    ELLIOTT, E
    FORTGENS, PH
    PIKE, RN
    DENNISON, C
    JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 136 (02) : 199 - 210
  • [42] Rational Design of a Humanized Antibody Inhibitor of Cathepsin B
    Dai, Zhefu
    Cheng, Qinqin
    Zhang, Yong
    BIOCHEMISTRY, 2020, 59 (14) : 1420 - 1427
  • [43] PRIMARY STRUCTURE STUDY OF RAT-LIVER CATHEPSIN-B - A STRIKING RESEMBLANCE TO PAPAIN
    TAKIO, K
    TOWATARI, T
    KATUNUMA, N
    TITANI, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 97 (01) : 340 - 346
  • [44] Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C
    Korkmaz, Brice
    Lesner, Adam
    Wysocka, Magdalena
    Gieldon, Artur
    Hakansson, Maria
    Gauthier, Francis
    Logan, Derek T.
    Jenne, Dieter E.
    Lauritzen, Conni
    Pedersen, John
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 349 - 367
  • [45] HUMAN OSTEOCLASTS EXPRESS ABUNDANT CATHEPSIN-O (OSTEOCLAST-SPECIFIC CYSTEINE PROTEINASE), BUT NOT CATHEPSIN-B, CATHEPSIN-L OR CATHEPSIN-S
    DODDS, RA
    JAMES, I
    CONNOR, J
    LEERYKACZEWSKI, E
    RICHARDSON, S
    DEBOUCK, C
    RIEMAN, D
    DRAKE, F
    GOWEN, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S228 - S228
  • [46] THE DESIGN OF PEPTIDYLDIAZOMETHANE INHIBITORS TO DISTINGUISH BETWEEN THE CYSTEINE PROTEINASES CALPAIN-II, CATHEPSIN-L AND CATHEPSIN-B
    CRAWFORD, C
    MASON, RW
    WIKSTROM, P
    SHAW, E
    BIOCHEMICAL JOURNAL, 1988, 253 (03) : 751 - 758
  • [47] Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold
    Swedberg, Joaidm E.
    Li, Choi Yi
    de Veer, Simon J.
    Wang, Conan K.
    Craik, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (02) : 658 - 667
  • [48] THE STRUCTURE OF THE BOVINE CATHEPSIN-B GENE - GENETIC-VARIABILITY IN THE 3'-UNTRANSLATED REGION
    MORDIER, SB
    BECHET, DM
    ROUX, MP
    OBLED, A
    FERRARA, MJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (01): : 35 - 44
  • [49] CORRELATION OF CATHEPSIN-B AND CYSTEINE PROTEINASE-INHIBITOR ACTIVITIES WITH LUNG COLONIZATION POTENTIAL IN MURINE TUMORS
    ROZHIN, J
    GOMEZ, AP
    ZIEGLE, GH
    NELSON, KK
    UMBARGER, LA
    LAH, TT
    ONODA, JM
    HONN, KV
    SLOANE, BF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 63 - 63
  • [50] PROCESSING AND MOLECULAR-FORMS OF CATHEPSIN-B IN HUMAN-TUMOR CELL-LINES
    MACH, L
    GLOSSL, J
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 870 - 870